Edition:
United Kingdom

Xenetic Biosciences Inc (XBIO.OQ)

XBIO.OQ on NASDAQ Stock Exchange Capital Market

2.87USD
9:00pm BST
Change (% chg)

$-0.11 (-3.69%)
Prev Close
$2.98
Open
$3.04
Day's High
$3.04
Day's Low
$2.81
Volume
33,507
Avg. Vol
121,589
52-wk High
$8.94
52-wk Low
$1.45

Chart for

About

Xenetic Biosciences, Inc. is a clinical-stage biopharmaceutical company. The Company focuses on discovery, research and development of biologic drugs and novel oncology therapeutics. The Company’s lead investigational product candidate is oncology therapeutic XBIO-101, which is used for the treatment of progestin - resistant... (more)
No analyst recommendations are available for .

Overall

Beta: 1.30
Market Cap(Mil.): $25.89
Shares Outstanding(Mil.): 8.72
Dividend: --
Yield (%): --

Financials

  XBIO.OQ Industry Sector
P/E (TTM): -- 85.68 32.76
EPS (TTM): -1.48 -- --
ROI: -72.68 1.78 14.61
ROE: -141.57 3.28 16.33

Competitors

  Price Chg
Actelion Ltd (ATLN.S) -- --
Incyte Corporation (INCY.OQ) $69.05 +0.25

Earnings vs. Estimates